Logo image of EAPI.PA

EUROAPI SASU (EAPI.PA) Stock Overview

EPA:EAPI - FR0014008VX5 - Common Stock

2.962 EUR
+0.1 (+3.57%)
Last: 9/11/2025, 5:28:12 PM

EAPI.PA Key Statistics, Chart & Performance

Key Statistics
52 Week High4.46
52 Week Low2.26
Market Cap283.14M
Shares95.59M
Float61.78M
Yearly Dividend0
Dividend YieldN/A
EPS(TTM)-1.31
PEN/A
Fwd PE872.05
Earnings (Next)03-03 2026-03-03/amc
IPO05-06 2022-05-06
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


EAPI.PA short term performance overview.The bars show the price performance of EAPI.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

EAPI.PA long term performance overview.The bars show the price performance of EAPI.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of EAPI.PA is 2.962 EUR. In the past month the price decreased by -8.45%. In the past year, price decreased by -33.95%.

EUROAPI SASU / EAPI Daily stock chart

EAPI.PA Competitors/Peers

The largest stocks on the EU markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY.DE ELI LILLY & CO 46.8 611.22B
1LLY.MI ELI LILLY & CO 46.36 605.55B
ZEG.DE ASTRAZENECA PLC 18.3 427.71B
1JNJ.MI JOHNSON & JOHNSON 17.79 365.97B
JNJ.DE JOHNSON & JOHNSON 17.7 364.09B
RHO.DE ROCHE HOLDING AG-BR 14.23 242.45B
NOT.DE NOVARTIS AG-REG 14.43 208.61B
NOV.DE NOVO NORDISK A/S-B 13.8 204.80B
SAN.PA SANOFI 10.69 196.92B
SNW.DE SANOFI 10.64 195.90B
1SAN.MI SANOFI 10.61 195.46B
6MK.DE MERCK & CO. INC. 10.93 179.59B

About EAPI.PA

Company Profile

EAPI logo image EUROAPI SA engages in manufacturing and supply of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,428 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Company Info

EUROAPI SASU

15, rue Traversiere

Paris ILE-DE-FRANCE FR

Employees: 3187

EAPI Company Website

EAPI Investor Relations

Phone: 33189206200

EUROAPI SASU / EAPI.PA FAQ

What is the stock price of EUROAPI SASU today?

The current stock price of EAPI.PA is 2.962 EUR. The price increased by 3.57% in the last trading session.


What is the ticker symbol for EUROAPI SASU stock?

The exchange symbol of EUROAPI SASU is EAPI and it is listed on the Euronext Paris - Matif exchange.


On which exchange is EAPI.PA stock listed?

EAPI.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for EUROAPI SASU stock?

13 analysts have analysed EAPI.PA and the average price target is 2.86 EUR. This implies a price decrease of -3.41% is expected in the next year compared to the current price of 2.962. Check the EUROAPI SASU stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is EUROAPI SASU worth?

EUROAPI SASU (EAPI.PA) has a market capitalization of 283.14M EUR. This makes EAPI.PA a Micro Cap stock.


How many employees does EUROAPI SASU have?

EUROAPI SASU (EAPI.PA) currently has 3187 employees.


What are the support and resistance levels for EUROAPI SASU (EAPI.PA) stock?

EUROAPI SASU (EAPI.PA) has a support level at 2.78 and a resistance level at 2.93. Check the full technical report for a detailed analysis of EAPI.PA support and resistance levels.


Is EUROAPI SASU (EAPI.PA) expected to grow?

The Revenue of EUROAPI SASU (EAPI.PA) is expected to decline by -2.6% in the next year. Check the estimates tab for more information on the EAPI.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EUROAPI SASU (EAPI.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EUROAPI SASU (EAPI.PA) stock pay dividends?

EAPI.PA does not pay a dividend.


When does EUROAPI SASU (EAPI.PA) report earnings?

EUROAPI SASU (EAPI.PA) will report earnings on 2026-03-03, after the market close.


What is the Price/Earnings (PE) ratio of EUROAPI SASU (EAPI.PA)?

EUROAPI SASU (EAPI.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.31).


EAPI.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

EAPI.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to EAPI.PA. EAPI.PA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

EAPI.PA Financial Highlights

Over the last trailing twelve months EAPI.PA reported a non-GAAP Earnings per Share(EPS) of -1.31. The EPS increased by 56.83% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.62%
ROE -13.04%
Debt/Equity 0.07
Chartmill High Growth Momentum
EPS Q2Q%18.35%
Sales Q2Q%-8.07%
EPS 1Y (TTM)56.83%
Revenue 1Y (TTM)-9.11%

EAPI.PA Forecast & Estimates

13 analysts have analysed EAPI.PA and the average price target is 2.86 EUR. This implies a price decrease of -3.41% is expected in the next year compared to the current price of 2.962.

For the next year, analysts expect an EPS growth of 62.94% and a revenue growth -2.6% for EAPI.PA


Analysts
Analysts46.15
Price Target2.86 (-3.44%)
EPS Next Y62.94%
Revenue Next Year-2.6%

EAPI.PA Ownership

Ownership
Inst Owners38.08%
Ins Owners0.01%
Short Float %N/A
Short RatioN/A